What Is Sermorelin?
TL;DR: Sermorelin is a GHRH analog with a genuine history as an FDA-approved drug (Geref), now mostly used off-label through compounding pharmacies or research-chemical channels to support natural GH release, especially for age-related decline.
Sermorelin is a peptide made up of the first 29 amino acids of naturally occurring growth hormone releasing hormone (GHRH) — the shortest fragment shown to retain full biological activity. It was FDA-approved in the 1990s under the brand name Geref for diagnosing and treating growth hormone deficiency before the manufacturer discontinued the product commercially.
How It Works
Sermorelin binds to GHRH receptors in the pituitary gland, prompting it to produce and release growth hormone in a pattern that closely mirrors the body’s own natural GH pulses — a key distinction from taking synthetic HGH directly, which bypasses the pituitary gland’s own regulatory feedback loop.
Who Uses It and Why
Sermorelin has a somewhat different user base than ipamorelin or CJC-1295 alone: it’s the GH secretagogue most likely to be encountered through an actual hormone-replacement clinic with lab monitoring, in addition to being available through the same research-chemical channels as other peptides on this list.